Table 3.
Demographics, mechanism of injury, physiology and injury severity between patients dying with (FTR) and without (non-precedented) serious adverse occurrences.
| Died | p | ||
|---|---|---|---|
| With Serious Adverse | Without Serious Adverse | ||
| Occurrences n=161 | Occurrences n=132 | ||
| Age in years | 59 (IQR 31–78) | 55 (IQR 31–78) | 0.87 |
| Male gender | 137 (79%) | 115 (65%) | <0.01 |
| Race | 0.13 | ||
| African American | 69 (40%) | 61 (35%) | |
| Caucasian | 87 (50%) | 105 (60%) | |
| Other | 17 (10%) | 10 (6%) | |
| Blunt Mechanism | 134(79%) | 141 (80%) | 0.60 |
| Unstable vitals | 73 (42%) | 75 (43%) | 1.00 |
| ISS | 29 (IQR 25–43) | 27 (IQR 25 –34) | 0.18 |
| Max AIS | 5 (IQR 4–5) | 5 (IQR 5–5) | 0.04 |
| Co-morbidities | |||
| COPD | 5 (2.9%) | 0 (0%) | 0.03 |
| Cirrhosis | 8 (4.6%) | 1 (0.6%) | 0.02 |
| Prior MI | 13 (7.5%) | 1 (0.6%) | <0.01 |
| Chemotherapy | 17 (9.8%) | 8 (4.6%) | 0.06 |
Non-parametric continuous values expressed as median (Interquartile Range); Categorical values expressed as n (%). P values are for Mann-Whitney or Fisher’s exact test, as appropriate. ISS= Injury Severity Score; AIS= Abbreviated Injury Scale; COPD = Chronic Obstructive Pulmonary Disease; MI = Myocardial Infarction.